Skip to main content
. 2019 Sep 11;1(9):e000057. doi: 10.1099/acmi.0.000057

Fig. 5.

Fig. 5.

Cross-neutralization of VSV-MERS-CoV-S by sera from patients with confirmed human coronavirus infections. VSV-MERS-CoV pseudoparticles were preincubated with equal volumes of two fold serially diluted MERS-CoV immune serum or antisera from the human coronaviruses 229E, HKU1, OC43, NL63 and SARS-CoV and then inoculated in triplicate onto Vero cells for each dilution of serum samples. The results are normalized to the negative control pNHS serum. The results are expressed as percentage neutralization and are the average of two independent experiments.